Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and ...

Medications known as GLP-1 receptor agonists have become some of the most popular treatments for weight loss in recent years. These drugs, originally developed to help people with diabetes control ...

Learn why experts advise against stopping and restarting GLP-1 drugs, the health risks of weight yo-yoing, and how to manage long-term weight loss safely.

For many people, recovery from a heart attack is a journey that requires careful lifestyle tweaks and long-term medication ...

Consumers filed over 200 complaints with some telemedicine companies for misleading customers about costs of weight loss using GLP-1 drugs.

A University of Virginia School of Medicine researcher has received $3.4 million from the National Institutes of Health to increase the availability of weight-management programs that offer beneficial ...

Tirzepatide, which is marketed as Zepbound for chronic weight management, is a dual GIP and GLP-1 receptor agonist that has ...

By Dennis Thompson HealthDay ReporterTHURSDAY, March 12, 2026 (HealthDay News) — People frequently switch between different weight-loss drugs, swapping Ozempic for Zepbound and vice versa within the ...

A diabetologist attributes his 37 kg weight loss to structured exercise and metabolic correction, emphasising insulin control and sustainable habits. | Health ...

Prescription weight loss drugs have been lauded as the miracle drug for treating diabetes and obesity, but new research suggests that these drugs, known as glucagon-like peptide-1 (GLP-1) ...

March 11, 2026) - Utopia Med Spa & Clinic, a Houston-based aesthetic and wellness center founded by board-certified plastic surgeon Dr. Franklin A. Rose, MD, today announced the expansion of its ...

Researchers at the University of California, Irvine Joe C. Wen School of Population & Public Health have identified how the hormone asprosin influences long-term weight change among postmenopausal ...